Company Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Business Summary
Sales per Business
ILS in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis
89.4
%
| 19 | 57.3 % | 38 | 89.4 % | +95.57% |
Cannabis Product Manufacturing Services
7.7
%
| 5 | 15.0 % | 3 | 7.7 % | -35.48% |
Marketing and Distribution Commissions
2.1
%
| 1 | 2.5 % | 1 | 2.1 % | +5.04% |
Laboratory Services
0.6
%
| 8 | 25.1 % | 0 | 0.6 % | -96.79% |
Other Income
0.1
%
| - | - | 0 | 0.1 % | - |
Sales per region
ILS in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 34 | 100.0 % | 42 | 100.0 % | +25.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 03/04/93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 31/12/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 64 | 14/07/19 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 03/04/93 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,293 | 1,952 ( 59.28 %) | 0 | 59.28 % |
Company contact information
Univo Pharmaceuticals Ltd.
20 HaHarash Street
7878320, Ashkelon
+
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+43.96% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |